Oric Pharmaceuticals (NASDAQ:ORIC – Free Report) had its target price boosted by JPMorgan Chase & Co. from $23.00 to $26.00 in a research report released on Wednesday morning,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the stock. ORIC has been the subject of several other research reports. Weiss Ratings restated a […]

Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price objective lifted by Jefferies Financial Group from $870.00 to $930.00 in a research note released on Thursday,Benzinga reports. The firm currently has a buy rating on the biopharmaceutical company’s stock. Several other research analysts have also recently weighed in on REGN. Cantor Fitzgerald boosted their price […]